BIRC5 and non-small cell lung carcinoma: Results from random-effect model suggested that survivin expression was significantly lower in NSCLC patients with well/moderate differentiation than that in the patients with poor differentiation (RR = 0.80, 95 % CI = 0.73-0.87, P < 0.001) (Fig. 4).